ArticleCancer biology & therapy2022

The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β.

Gang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.